STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2016 USD ($) shares	Apr. 03, 2015 USD ($) shares	Apr. 01, 2016 € / shares	Apr. 01, 2016 USD ($) shares	Apr. 03, 2015 USD ($) shares	Apr. 01, 2016 USD ($) shares	Jan. 01, 2016 shares	Nov. 30, 2015 shares	Oct. 02, 2015 shares	[1]	Apr. 30, 2015
Stockholders’ equity and noncontrolling interests [Line Items]
Number of shares authorized to be repurchased by VMS Board of Directors								8,000,000
Repurchases of common stock | $				$ 248,704	$ 201,181
Common stock, shares outstanding (in shares)						95,550,000			98,070,000
Number of shares	725,000	825,000		3,150,000	2,325,000
Noncontrolling Interests
Stockholders’ equity and noncontrolling interests [Line Items]
Redemption value | $						$ 10,300
MeVis Medical Solutions AG (MeVis)
Stockholders’ equity and noncontrolling interests [Line Items]
Annual recurring compensation (in euro per share) | € / shares			€ 0.95
Put right (in euro per share) | € / shares			€ 19.77
Percentage of voting interest acquired											73.50%
MeVis Medical Solutions AG (MeVis) | Noncontrolling Interests
Stockholders’ equity and noncontrolling interests [Line Items]
Common stock, shares outstanding (in shares)						480,000
Noncontrolling interest (as a percent)						26.40%
Accelerated Share Repurchase Program
Stockholders’ equity and noncontrolling interests [Line Items]
Repurchases of common stock | $	$ 40,400	$ 45,000		$ 40,400	$ 45,000
Number of shares remain available for repurchase							6,300,000
Number of shares	500,000	500,000		500,000	500,000

[1] The condensed consolidated balance sheet as of October 2, 2015 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.